Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Analyst Upgrades and Downgrades
NUS has been the subject of several recent analyst reports. StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Wednesday, June 22nd. TheStreet cut shares of Nu Skin Enterprises from a "b" rating to a "c" rating in a report on Thursday. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, Nu Skin Enterprises currently has an average rating of "Moderate Buy" and an average price target of $61.50.
Nu Skin Enterprises Stock Performance
Shares of Nu Skin Enterprises stock traded down $1.25 during trading on Friday, reaching $43.35. The company's stock had a trading volume of 520,423 shares, compared to its average volume of 345,016. The company has a current ratio of 1.72, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. The firm has a market cap of $2.18 billion, a PE ratio of 19.53 and a beta of 1.16. The company has a 50-day moving average price of $44.22 and a two-hundred day moving average price of $46.47. Nu Skin Enterprises has a fifty-two week low of $39.40 and a fifty-two week high of $56.76.
Nu Skin Enterprises (NYSE:NUS - Get Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.03. The company had revenue of $604.90 million for the quarter, compared to analysts' expectations of $579.70 million. Nu Skin Enterprises had a net margin of 4.57% and a return on equity of 19.85%. Nu Skin Enterprises's revenue was down 10.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.91 EPS. On average, analysts forecast that Nu Skin Enterprises will post 3.55 EPS for the current year.
Nu Skin Enterprises Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 7th. Shareholders of record on Friday, August 26th will be issued a $0.385 dividend. The ex-dividend date is Thursday, August 25th. This represents a $1.54 dividend on an annualized basis and a yield of 3.55%. Nu Skin Enterprises's dividend payout ratio (DPR) is 69.37%.
Insider Buying and Selling at Nu Skin Enterprises
In other Nu Skin Enterprises news, CFO Mark H. Lawrence sold 5,868 shares of the company's stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $47.03, for a total value of $275,972.04. Following the transaction, the chief financial officer now directly owns 48,218 shares in the company, valued at approximately $2,267,692.54. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, Director Andrew D. Lipman sold 1,000 shares of the company's stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $43.00, for a total transaction of $43,000.00. Following the completion of the transaction, the director now owns 71,393 shares of the company's stock, valued at approximately $3,069,899. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Mark H. Lawrence sold 5,868 shares of the company's stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $47.03, for a total transaction of $275,972.04. Following the transaction, the chief financial officer now directly owns 48,218 shares of the company's stock, valued at approximately $2,267,692.54. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 148,143 shares of company stock worth $6,647,717. Corporate insiders own 2.80% of the company's stock.
